These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 36058230)

  • 1. Prehospital transdermal glyceryl trinitrate in patients with presumed acute stroke (MR ASAP): an ambulance-based, multicentre, randomised, open-label, blinded endpoint, phase 3 trial.
    van den Berg SA; Uniken Venema SM; Reinink H; Hofmeijer J; Schonewille WJ; Miedema I; Fransen PSS; O Pruissen DM; Raaijmakers TWM; van Dijk GW; de Leeuw FE; van Vliet JA; Kwa VIH; Kerkhoff H; van 't Net A; Boomars R; Siegers A; Lok T; Caminada K; Esteve Cuevas LM; Visser MC; Zwetsloot CP; Boomsma JMF; Schipper MH; van Eijkelenburg RPJ; Berkhemer OA; Nieboer D; Lingsma HF; Emmer BJ; van Oostenbrugge RJ; van der Lugt A; Roos YBWEM; Majoie CBLM; Dippel DWJ; Nederkoorn PJ; van der Worp HB;
    Lancet Neurol; 2022 Nov; 21(11):971-981. PubMed ID: 36058230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial.
    RIGHT-2 Investigators
    Lancet; 2019 Mar; 393(10175):1009-1020. PubMed ID: 30738649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicentre Randomised trial of Acute Stroke treatment in the Ambulance with a nitroglycerin Patch (MR ASAP): study protocol for a randomised controlled trial.
    van den Berg SA; Dippel DWJ; Hofmeijer J; Fransen PSS; Caminada K; Siegers A; Kruyt ND; Kerkhoff H; de Leeuw FE; Nederkoorn PJ; van der Worp HB;
    Trials; 2019 Jun; 20(1):383. PubMed ID: 31242931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-hospital transdermal glyceryl trinitrate in patients with stroke mimics: data from the RIGHT-2 randomised-controlled ambulance trial.
    Tunnage B; Woodhouse LJ; Dixon M; Anderson C; Ankolekar S; Appleton J; Cala L; England T; Krishnan K; Havard D; Mair G; Muir K; Phillips S; Potter J; Price C; Randall M; Robinson TG; Roffe C; Sandset E; Siriwardena N; Scutt P; Wardlaw JM; Sprigg N; Bath PM;
    BMC Emerg Med; 2022 Jan; 22(1):2. PubMed ID: 35012462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endovascular treatment versus no endovascular treatment after 6-24 h in patients with ischaemic stroke and collateral flow on CT angiography (MR CLEAN-LATE) in the Netherlands: a multicentre, open-label, blinded-endpoint, randomised, controlled, phase 3 trial.
    Olthuis SGH; Pirson FAV; Pinckaers FME; Hinsenveld WH; Nieboer D; Ceulemans A; Knapen RRMM; Robbe MMQ; Berkhemer OA; van Walderveen MAA; Lycklama À Nijeholt GJ; Uyttenboogaart M; Schonewille WJ; van der Sluijs PM; Wolff L; van Voorst H; Postma AA; Roosendaal SD; van der Hoorn A; Emmer BJ; Krietemeijer MGM; van Doormaal PJ; Roozenbeek B; Goldhoorn RB; Staals J; de Ridder IR; van der Leij C; Coutinho JM; van der Worp HB; Lo RTH; Bokkers RPH; van Dijk EI; Boogaarts HD; Wermer MJH; van Es ACGM; van Tuijl JH; Kortman HGJ; Gons RAR; Yo LSF; Vos JA; de Laat KF; van Dijk LC; van den Wijngaard IR; Hofmeijer J; Martens JM; Brouwers PJAM; Bulut T; Remmers MJM; de Jong TEAM; den Hertog HM; van Hasselt BAAM; Rozeman AD; Elgersma OEH; van der Veen B; Sudiono DR; Lingsma HF; Roos YBWEM; Majoie CBLM; van der Lugt A; Dippel DWJ; van Zwam WH; van Oostenbrugge RJ;
    Lancet; 2023 Apr; 401(10385):1371-1380. PubMed ID: 37003289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collateral-based selection for endovascular treatment of acute ischaemic stroke in the late window (MR CLEAN-LATE): 2-year follow-up of a phase 3, multicentre, open-label, randomised controlled trial in the Netherlands.
    Huijberts I; Pinckaers FME; Olthuis SGH; van Kuijk SMJ; Postma AA; Boogaarts HD; Roos YBWEM; Majoie CBLM; van der Lugt A; Dippel DWJ; van Zwam WH; van Oostenbrugge RJ;
    Lancet Neurol; 2024 Sep; 23(9):893-900. PubMed ID: 38909624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ambulance-delivered transdermal glyceryl trinitrate versus sham for ultra-acute stroke: Rationale, design and protocol for the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial-2 (RIGHT-2) trial (ISRCTN26986053).
    Appleton JP; Scutt P; Dixon M; Howard H; Haywood L; Havard D; Hepburn T; England T; Sprigg N; Woodhouse LJ; Wardlaw JM; Montgomery AA; Pocock S; Bath PM;
    Int J Stroke; 2019 Feb; 14(2):191-206. PubMed ID: 28762896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of aspirin, unfractionated heparin, both, or neither during endovascular stroke treatment (MR CLEAN-MED): an open-label, multicentre, randomised controlled trial.
    van der Steen W; van de Graaf RA; Chalos V; Lingsma HF; van Doormaal PJ; Coutinho JM; Emmer BJ; de Ridder I; van Zwam W; van der Worp HB; van der Schaaf I; Gons RAR; Yo LSF; Boiten J; van den Wijngaard I; Hofmeijer J; Martens J; Schonewille W; Vos JA; Tuladhar AM; de Laat KF; van Hasselt B; Remmers M; Vos D; Rozeman A; Elgersma O; Uyttenboogaart M; Bokkers RPH; van Tuijl J; Boukrab I; van den Berg R; Beenen LFM; Roosendaal SD; Postma AA; Krietemeijer M; Lycklama G; Meijer FJA; Hammer S; van der Hoorn A; Yoo AJ; Gerrits D; Truijman MTB; Zinkstok S; Koudstaal PJ; Manschot S; Kerkhoff H; Nieboer D; Berkhemer O; Wolff L; van der Sluijs PM; van Voorst H; Tolhuisen M; Roos YBWEM; Majoie CBLM; Staals J; van Oostenbrugge RJ; Jenniskens SFM; van Dijk LC; den Hertog HM; van Es ACGM; van der Lugt A; Dippel DWJ; Roozenbeek B;
    Lancet; 2022 Mar; 399(10329):1059-1069. PubMed ID: 35240044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised controlled trial.
    ENOS Trial Investigators
    Lancet; 2015 Feb; 385(9968):617-628. PubMed ID: 25465108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prehospital transdermal glyceryl trinitrate for ultra-acute ischaemic stroke: data from the RIGHT-2 randomised sham-controlled ambulance trial.
    Appleton JP; Woodhouse LJ; Anderson CS; Ankolekar S; Cala L; Dixon M; England TJ; Krishnan K; Mair G; Muir KW; Potter J; Price CI; Randall M; Robinson TG; Roffe C; Sandset EC; Saver JL; Shone A; Siriwardena AN; Wardlaw JM; Sprigg N; Bath PM;
    Stroke Vasc Neurol; 2024 Feb; 9(1):38-49. PubMed ID: 37290930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time intervals and distances travelled for prehospital ambulance stroke care: data from the randomised-controlled ambulance-based Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial-2 (RIGHT-2).
    Dixon M; Appleton JP; Scutt P; Woodhouse LJ; Haywood LJ; Havard D; Williams J; Siriwardena AN; Bath PM;
    BMJ Open; 2022 Nov; 12(11):e060211. PubMed ID: 36410799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline characteristics of the 1149 patients recruited into the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial-2 (RIGHT-2) randomized controlled trial.
    Bath PM; Scutt P; Appleton JP; Dixon M; Woodhouse LJ; Wardlaw JM; Sprigg N
    Int J Stroke; 2019 Apr; 14(3):298-305. PubMed ID: 30475165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke (ENCHANTED2/MT): a multicentre, open-label, blinded-endpoint, randomised controlled trial.
    Yang P; Song L; Zhang Y; Zhang X; Chen X; Li Y; Sun L; Wan Y; Billot L; Li Q; Ren X; Shen H; Zhang L; Li Z; Xing P; Zhang Y; Zhang P; Hua W; Shen F; Zhou Y; Tian B; Chen W; Han H; Zhang L; Xu C; Li T; Peng Y; Yue X; Chen S; Wen C; Wan S; Yin C; Wei M; Shu H; Nan G; Liu S; Liu W; Cai Y; Sui Y; Chen M; Zhou Y; Zuo Q; Dai D; Zhao R; Li Q; Huang Q; Xu Y; Deng B; Wu T; Lu J; Wang X; Parsons MW; Butcher K; Campbell B; Robinson TG; Goyal M; Dippel D; Roos Y; Majoie C; Wang L; Wang Y; Liu J; Anderson CS;
    Lancet; 2022 Nov; 400(10363):1585-1596. PubMed ID: 36341753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prehospital Transdermal Glyceryl Trinitrate for Ultra-Acute Intracerebral Hemorrhage: Data From the RIGHT-2 Trial.
    Bath PM; Woodhouse LJ; Krishnan K; Appleton JP; Anderson CS; Berge E; Cala L; Dixon M; England TJ; Godolphin PJ; Hepburn T; Mair G; Montgomery AA; Phillips SJ; Potter J; Price CI; Randall M; Robinson TG; Roffe C; Rothwell PM; Sandset EC; Sanossian N; Saver JL; Siriwardena AN; Venables G; Wardlaw JM; Sprigg N
    Stroke; 2019 Nov; 50(11):3064-3071. PubMed ID: 31587658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): effects on outcomes at day 365 in a randomised, sham-controlled, blinded, phase III, superiority ambulance-based trial.
    Woodhouse LJ; Appleton JP; Ankolekar S; England TJ; Mair G; Muir K; Price CI; Pocock S; Randall M; Robinson TG; Roffe C; Sandset EC; Saver JL; Siriwardena AN; Sprigg N; Wardlaw JM; Bath PM;
    BMJ Neurol Open; 2023; 5(1):e000424. PubMed ID: 37564156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial.
    Anderson CS; Huang Y; Lindley RI; Chen X; Arima H; Chen G; Li Q; Billot L; Delcourt C; Bath PM; Broderick JP; Demchuk AM; Donnan GA; Durham AC; Lavados PM; Lee TH; Levi C; Martins SO; Olavarria VV; Pandian JD; Parsons MW; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Silva F; Song L; Thang NH; Wardlaw JM; Wang JG; Wang X; Woodward M; Chalmers J; Robinson TG;
    Lancet; 2019 Mar; 393(10174):877-888. PubMed ID: 30739745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of an ambulance-based stroke trial, and safety of glyceryl trinitrate in ultra-acute stroke: the rapid intervention with glyceryl trinitrate in Hypertensive Stroke Trial (RIGHT, ISRCTN66434824).
    Ankolekar S; Fuller M; Cross I; Renton C; Cox P; Sprigg N; Siriwardena AN; Bath PM
    Stroke; 2013 Nov; 44(11):3120-8. PubMed ID: 24003041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF): a randomised, open-label, phase 2 trial.
    Schreuder FHBM; van Nieuwenhuizen KM; Hofmeijer J; Vermeer SE; Kerkhoff H; Zock E; Luijckx GJ; Messchendorp GP; van Tuijl J; Bienfait HP; Booij SJ; van den Wijngaard IR; Remmers MJM; Schreuder AHCML; Dippel DW; Staals J; Brouwers PJAM; Wermer MJH; Coutinho JM; Kwa VIH; van Gelder IC; Schutgens REG; Zweedijk B; Algra A; van Dalen JW; Jaap Kappelle L; Rinkel GJE; van der Worp HB; Klijn CJM;
    Lancet Neurol; 2021 Nov; 20(11):907-916. PubMed ID: 34687635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of tenecteplase with alteplase for the early treatment of ischaemic stroke in the Melbourne Mobile Stroke Unit (TASTE-A): a phase 2, randomised, open-label trial.
    Bivard A; Zhao H; Churilov L; Campbell BCV; Coote S; Yassi N; Yan B; Valente M; Sharobeam A; Balabanski AH; Dos Santos A; Ng JL; Yogendrakumar V; Ng F; Langenberg F; Easton D; Warwick A; Mackey E; MacDonald A; Sharma G; Stephenson M; Smith K; Anderson D; Choi P; Thijs V; Ma H; Cloud GC; Wijeratne T; Olenko L; Italiano D; Davis SM; Donnan GA; Parsons MW;
    Lancet Neurol; 2022 Jun; 21(6):520-527. PubMed ID: 35525251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial.
    Baharoglu MI; Cordonnier C; Al-Shahi Salman R; de Gans K; Koopman MM; Brand A; Majoie CB; Beenen LF; Marquering HA; Vermeulen M; Nederkoorn PJ; de Haan RJ; Roos YB;
    Lancet; 2016 Jun; 387(10038):2605-2613. PubMed ID: 27178479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.